In 2005, the board of directors of the American Academy of Pediatrics (AAP) adopted a policy supporting relationships with companies that, “through their products, activities, and/or their philosophy, enhance the quality of life for children and their families and are aligned with the AAP’s values and mission” (https://www.aap.org/en-us/about-the-aap/aap-leadership/Documents/20-IndustryRelations.pdf). In doing so, the organization chose to apply a higher standard than simply asking whether corporate funding can be put to good use. Under this policy, the AAP should reassess its engagement with companies that sell infant formula.
Sharfstein JM, Silver DL. Relationship Between the American Academy of Pediatrics and Infant Formula Companies. JAMA Pediatr. 2017;171(7):613–614. doi:10.1001/jamapediatrics.2017.1257
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.